Related Experiment Video
Updated: May 12, 2026

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
Published on: May 30, 2012
Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in
Lei Wang1, Zhang-Yan Guo, Rui Zhang
1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an, China. rna_research@yahoo.cn
Abstract:
The POU transcription factor OCT4 is a pleiotropic regulator of gene expression in embryonic stem cells. Recent studies demonstrated that OCT4 is aberrantly expressed in multiple types of human cancer; however, the underlying molecular mechanism remains largely unknown. In this study, we report that OCT4-pg4, a pseudogene of OCT4, is abnormally activated in hepatocellular carcinoma (HCC). The expression level of OCT4-pg4 is positively correlated with that of OCT4, and both gene transcripts can be directly targeted by a tumor-suppressive micro RNA miR-145. We find that the non-coding RNA OCT4-pg4 is biologically active, as it can upregulate OCT4 protein level in HCC. Mechanistic analysis revealed that OCT4-pg4 functions as a natural micro RNA sponge to protect OCT4 transcript from being inhibited by miR-145. In addition, our study also showed that OCT4-pg4 can promote growth and tumorigenicity of HCC cells, thus exerting an oncogenic role in hepatocarcinogenesis. Furthermore, survival analysis suggests that high OCT4-pg4 level is significantly correlated with poor prognosis of HCC patients. Taken together, our finding adds a new layer of post-transcriptional regulation of OCT4 and sheds new light on the treatment of human HCC.
Insights
A pseudogene of OCT4, OCT4-pg4, is activated in hepatocellular carcinoma (HCC). This non-coding RNA promotes HCC growth and poor prognosis by sponging miR-145, upregulating OCT4.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- OCT4 is a key regulator in embryonic stem cells.
- Aberrant OCT4 expression is linked to various human cancers.
- The molecular mechanisms driving OCT4 dysregulation in cancer are largely unknown.
Purpose of the Study:
- To investigate the role of OCT4 pseudogenes in hepatocellular carcinoma (HCC).
- To elucidate the mechanism by which OCT4 pseudogenes contribute to HCC development.
- To explore the potential of OCT4-pg4 as a prognostic marker for HCC.
Main Methods:
- Analysis of gene expression levels in HCC tissues.
- Investigation of microRNA targeting using luciferase assays.
- Assessment of cell growth and tumorigenicity in vitro and in vivo.
- Correlation analysis between OCT4-pg4 levels and patient survival.
Main Results:
- OCT4-pg4, a pseudogene of OCT4, is abnormally activated in HCC.
- OCT4-pg4 acts as a microRNA sponge for miR-145, protecting OCT4 transcripts.
- OCT4-pg4 promotes HCC cell growth and tumorigenicity, correlating with poor patient prognosis.
Conclusions:
- OCT4-pg4 plays an oncogenic role in hepatocarcinogenesis.
- OCT4-pg4 represents a novel layer of OCT4 post-transcriptional regulation.
- OCT4-pg4 may serve as a potential therapeutic target and prognostic biomarker for HCC.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Somatic to iPS Cell Reprogramming
Experimental RNAi
lncRNA - Long Non-coding RNAs